MedTrace Logo

Human Biological Responses to Low Level Ozone

NCT02857283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-05-14

Study results available
· View outcomes & findings →

Summary

To investigate if low level ozone exposure will cause measurable inflammation in nasal cells.

Conditions

  • Environmental Exposure
  • Nasal Inflammation

Interventions

OTHER

Ozone

Participants will be exposed to a concentration of ozone for 6.5 hours at a concentration that varies 0.06 to 0.08

OTHER

Filtered Air

Participants will be exposed to filtered clean air

DEVICE

Health and Exposure Tracker (HET)

Ozone and heart rate tracker

Sponsors & Collaborators

  • Environmental Protection Agency (EPA)

    collaborator FED

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • David B Peden, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-22
Primary Completion
2019-05-01
Completion
2019-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02857283 on ClinicalTrials.gov